Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology, October 2022
Volume46
Issue 10
Pages: 12

Next-Generation Synthetic Biology Workflow Platform

Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.

Codex DNA’s BioXp 9600 System

Codex DNA’s BioXp 9600 System

Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences. Designed for use with synthetic biology workflows, the system provides overnight, automated synthesis of genes, clones, DNA libraries, and mRNA. It is capable of processing up to 96 gene fragments overnight.

The system features a unique instrument design that is intended to minimize benchtop footprint while also increasing throughput and versatility. Proprietary error correction and Gibson assembly technology automate the identification and removal of mismatches introduced during synthesis and assembly.

Codex DNA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com